Advisory Committee
- Date: 2020-04-01
- Update: 2022-01-21
- Source:
- Views: 1922
October 1, 2021 - September 30, 2024
| NAME | POSITION |
|---|---|
|
Hsin-Su Yu
(Convener) |
Chair Professor, Graduate Institute of Clinical Medicine and Department of Dermatology, Kaohsiung Medical University |
| Deh-Ming Chang | Medical Adviser, Taipei Veterans General Hospital, Taiwan, ROC Professor Emeritus, National Defense Medical Center, Taiwan, ROC |
| Shan-Chwen Chang | Executive Vice President, National Taiwan University Professor, Department of Internal Medicine, National Taiwan University, College of Medicine Attending Physician, Department of Internal Medicine, National Taiwan University Hospital |
|
Yung-Chi Cheng
|
Academician, Academia Sinica Henry Bronson Professor of Pharmacology School of Medicine, Yale University, USA Chairman, Consortium for Globalization of Chinese Medicine (CGCM) |
|
Chien Ho
|
Academician, Academia Sinica |
|
Eva Y.-H. P. Lee
|
Academician and Distinguished Visiting Chair Genomics Research Center, Academia Sinica Chancellor's Professor Department of Biological Chemistry University of California, Irvine, USA |
|
Horace H. Loh
|
Academician, Academia Sinica Regents Professor, Frederick and Alice Stark Professor, and Head of Pharmacology Department, Medical School, University of Minnesota, USA (Emeritus) |
| Shio-Jea Lin | Hsu Wen-Lung Chair Professor |
|
Jo Shen
|
Vivo Capital, Venture Partner |
| Chin-Tay Shih | Honorary Chair, College of Technology Management, National Tsing Hua University |
| Yu-Hsin Yang | CEO of Patient Autonomy Research Center, Taiwan Life Education Association Honorary Consultant of the Legislative Yuan Director of Taiwan Organ Sharing Registry and Patient Autonomy Promotion Center Executive Director of Taiwan Organization for Disadvantaged Patients |
|
Meng-Chao Yao
|
Academician and Distinguished Research Fellow |
|
Edward T.H. Yeh
|
Academician, Academia Sinica |
| Karen Wen | COO & Chief Strategy Officer GenomeFrontier Therapeutics, Inc. |